Literature DB >> 3027230

Arginine infusion blocks the action of parathyroid hormone but not arginine vasopressin on the renal tubule in man.

D S O'Reilly, W D Fraser, M D Penney, F C Logue, R A Cowan, B C Williams, G Walters.   

Abstract

Six male volunteers were infused with arginine (0.5 g/kg body weight) over 30 min, after an overnight fast and water deprivation. There was a significant decrease in renal phosphate clearance (P less than 0.025) and urinary cyclic adenosine monophosphate (cAMP) output (P less than 0.025) during the 60- to 90-min period after the beginning of the infusion; both returned to the preinfusion basal levels within 150 min. The plasma levels of parathyroid hormone (PTH) were not affected by the infusion and remained unchanged during the subsequent 150 min. Plasma levels of arginine vasopressin (AVP) were also not significantly affected although plasma osmolality increased by 6-9 mmol/kg in all subjects. The infusion resulted in a diuresis, and a fall in urine osmolality but a decrease in free-water clearance; creatinine clearance was not affected. Six other subjects were given a bolus of 230 i.u. PTH intravenously, and 20 days later this was repeated during an infusion of arginine (0.5 g/kg body weight). There was a significant decrease in urinary phosphate (P less than 0.025) and cAMP excretion (P less than 0.05) when PTH was given with arginine. It is suggested that arginine blocks the action of PTH on the proximal renal tubule but not that of vasopressin on the distal nephron and collecting ducts.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3027230     DOI: 10.1677/joe.0.1110501

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  4 in total

1.  The effect of lithium on the renal response to the dopamine prodrug gludopa in normal man.

Authors:  R F Jeffrey; T M Macdonald; J Brown; P W Rae; M R Lee
Journal:  Br J Clin Pharmacol       Date:  1988-06       Impact factor: 4.335

2.  Factors predicting the acute effect of pamidronate on serum calcium in hypercalcemia of malignancy.

Authors:  S J Gallacher; W D Fraser; F C Logue; F J Dryburgh; R A Cowan; I T Boyle; S H Ralston
Journal:  Calcif Tissue Int       Date:  1992-12       Impact factor: 4.333

3.  Development of meloxicam salts with improved dissolution and pharmacokinetic behaviors in rats with impaired gastric motility.

Authors:  Masanori Ochi; Ryo Inoue; Yukinori Yamauchi; Shizuo Yamada; Satomi Onoue
Journal:  Pharm Res       Date:  2012-09-15       Impact factor: 4.200

4.  Analgesia with ibuprofen arginate versus conventional ibuprofen for patients with dysmenorrhea: a crossover trial.

Authors:  Donald R Mehlisch; Alfredo Ardia; Teresa Pallotta
Journal:  Curr Ther Res Clin Exp       Date:  2003-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.